Home › Oropharyngeal Cancer › Massachusetts › Boston
Oropharyngeal Cancer clinical trials in Boston, MA
3 studies for Oropharyngeal Cancer are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
RecruitingPhase 3
- Dana Faber Cancer Institute, Boston
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- Boston Medical Center, Boston
Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
RecruitingPhase 2
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Oropharyngeal Cancer trials in other cities
- Chicago, IL9 studies
- Edison, NJ8 studies
- Atlanta, GA7 studies
- New York City, NY7 studies
- St. Louis, MO7 studies
- Omaha, NE7 studies
- Tampa, FL6 studies
- Houston, TX6 studies
- Detroit, MI6 studies
- Baltimore, MD6 studies
- Pittsburgh, PA6 studies
- Los Angeles, CA6 studies
Other studies in Boston
- Breast Cancer110 studies
- Cancer (all types)90 studies
- Non-Small Cell Lung Cancer87 studies
- Lung Cancer63 studies
- Colorectal Cancer62 studies
- Ovarian Cancer62 studies
- Metastatic Cancer61 studies
- Prostate Cancer56 studies
- Endometrial Cancer51 studies
- Depression50 studies
- Heart Failure46 studies
- Multiple Myeloma45 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.